Dr Jonathan Dick |
12:00 - 1:00pm, Seminar
Room 1, Level 2, TRF Building
Dr Jonathan
Dick
Nephrologist,
Department of Nephrology, Monash Health
Postgraduate
Student, Centre for Inflammatory Diseases
New Roles for Complement in
ANCA associated Vasculitis
Dr Jonathan Dick is a clinician studying for a PhD
supervised by Professors Stephen Holdsworth and Richard Kitching. He read
Medicine at the University of Oxford and University College London before
training in General Medicine and Nephrology in London. His research interest is
in the role of the complement system in ANCA associated vasculitis.
Mr Nathan Kuk
Postgraduate Student, Centre for
Inflammatory Diseases
Human Amniotic Epithelial Cells in Hepatic and
Gastrointestinal Disorders
Human Amniotic Epithelial Cells
(hAECs) are an exciting new form of stem cell therapy used extensively in
dermatology, ophthalmology and most recently, respiratory medicine. Displaying
anti-inflammatory and anti-fibrotic properties, hAECs possess numerous
advantages over more traditional forms of cellular therapy. Their use in
hepatic and gastrointestinal disorders however is not as well documented.
Overtaking viral hepatitis and alcoholic liver disease as the main causes of
chronic liver disease, the incidence and prevalence of non-alcoholic fatty
liver disease (NAFLD) is dramatically increasing due to its association with
obesity and the metabolic syndrome. A proportion of patients with NAFLD
eventually develop steatohepatitis (NASH), increasing their risk of cirrhosis
and hepatic carcinoma. Alarmingly, there are no effective therapies for NAFLD
and NASH and transplantation remains the only cure in cases of cirrhosis. As
such, this posits the question, could hAECs
be used to treat NAFLD?
This is the last seminar for 2016.
CID seminars will commence again in mid February.
Further information, including the link to add the seminar series to your google calendar, is available from CID Weekly Seminar Series website [http://www.med.monash.edu.au/scs/medicine/cid/seminar-series.html]
No comments:
Post a Comment